{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:15:24Z","timestamp":1789128924806,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-05017-w","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:02:02Z","timestamp":1683864122000},"page":"3325-3335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical usefulness of anti-nuclear antibody in childhood: real-world experience at a tertiary care center"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-6952","authenticated-orcid":false,"given":"Nihal","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-9922","authenticated-orcid":false,"given":"Ay\u015fenur Pa\u00e7","family":"K\u0131saarslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3290-4413","authenticated-orcid":false,"given":"S\u00fcmeyra \u00d6zdemir","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-4378","authenticated-orcid":false,"given":"Ay\u015fe Seda","family":"P\u0131narba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0995-8501","authenticated-orcid":false,"given":"Neslihan","family":"G\u00fcnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5707-1633","authenticated-orcid":false,"given":"Sibel","family":"Yel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-4344","authenticated-orcid":false,"given":"\u0130smail","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-8432","authenticated-orcid":false,"given":"Muammer Hakan","family":"Poyrazo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0599-7199","authenticated-orcid":false,"given":"Ruhan","family":"D\u00fc\u015f\u00fcnsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"5017_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/BMJ.2.5047.732","volume":"2","author":"EJ Holborow","year":"1957","unstructured":"Holborow EJ, Weir DM, Johnson GD (1957) A Serum Factor in Lupus Erythematosus with Affinity for Tissue Nuclei. Br Med J 2:732. https:\/\/doi.org\/10.1136\/BMJ.2.5047.732","journal-title":"Br Med J"},{"key":"5017_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3181\/00379727-96-23545","volume":"96","author":"WC Robbins","year":"1957","unstructured":"Robbins WC, Holman HR, Deicher H, Kunkel HG (1957) Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med 96:575\u2013579. https:\/\/doi.org\/10.3181\/00379727-96-23545","journal-title":"Proc Soc Exp Biol Med"},{"key":"5017_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/J.CLL.2019.07.001","volume":"39","author":"M Ling","year":"2019","unstructured":"Ling M, Murali M (2019) Antinuclear Antibody Tests. Clin Lab Med 39:513\u2013524. https:\/\/doi.org\/10.1016\/J.CLL.2019.07.001","journal-title":"Clin Lab Med"},{"key":"5017_CR4","unstructured":"American College of Rheumatology Position Statement Subject: Methodology of Testing for Antinuclear Antibodies. Available online: https:\/\/www.rheumatology.org\/Practice\/Clinical\/Position\/Position_Statements\/. Accessed 3 Feb 2022"},{"key":"5017_CR5","doi-asserted-by":"publisher","unstructured":"Fitch-Rogalsky C, Steber W, Mahler M, Lupton T, Martin L, Barr SG, Mosher DP, Wick J, Fritzler MJ (2014) Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS One 9:e93812. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0093812","DOI":"10.1371\/JOURNAL.PONE.0093812"},{"key":"5017_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1515\/CCLM-2017-0241","volume":"56","author":"D P\u00e9rez","year":"2018","unstructured":"P\u00e9rez D, Gilburd B, Cabrera-Marante \u00d3 et al (2018) Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies. Clin Chem Lab Med 56:1771\u20131777. https:\/\/doi.org\/10.1515\/CCLM-2017-0241","journal-title":"Clin Chem Lab Med"},{"key":"5017_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S121632","volume":"9","author":"EC Somers","year":"2016","unstructured":"Somers EC, Monrad SU, Warren JS, Solano M, Schnaas L, Hernandez-Avila M, Tellez-Rojo MM, Hu H (2016) Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays. Clin Epidemiol 9:1\u20138. https:\/\/doi.org\/10.2147\/CLEP.S121632","journal-title":"Clin Epidemiol"},{"key":"5017_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/J.CURTHERES.2014.06.004","volume":"76","author":"YP Guo","year":"2014","unstructured":"Guo YP, Wang CG, Liu X et al (2014) The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study. Curr Ther Res Clin Exp 76:116\u2013119. https:\/\/doi.org\/10.1016\/J.CURTHERES.2014.06.004","journal-title":"Curr Ther Res Clin Exp"},{"key":"5017_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/S00296-016-3533-0","volume":"36","author":"E Racoubian","year":"2016","unstructured":"Racoubian E, Zubaid RM, Shareef MA, Almawi WY (2016) Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008\u20132015: a cross-sectional study involving 10,814 subjects. Rheumatol Int 36:1231\u20131236. https:\/\/doi.org\/10.1007\/S00296-016-3533-0","journal-title":"Rheumatol Int"},{"key":"5017_CR10","first-page":"932","volume":"93","author":"I Afman","year":"2003","unstructured":"Afman I, Cronj\u00e9 H, Joubert G, Badenhorst P, Schoon M (2003) Antinuclear antibody testing in obstetric patients. S Afr Med J 93:932\u2013937","journal-title":"S Afr Med J"},{"key":"5017_CR11","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/ART.34380","volume":"64","author":"M Satoh","year":"2012","unstructured":"Satoh M, Chan EKL, Ho LA et al (2012) Prevalence and Sociodemographic Correlates of Antinuclear Antibodies In the United States. Arthritis Rheum 64:2319. https:\/\/doi.org\/10.1002\/ART.34380","journal-title":"Arthritis Rheum"},{"key":"5017_CR12","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1002\/art.34651","volume":"64","author":"BF Bruner","year":"2012","unstructured":"Bruner BF, Guthridge JM, Lu R et al (2012) Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of SLE patients and family members $watermark-text $watermark-text $watermark-text. Arthritis Rheum 64:3677\u20133686. https:\/\/doi.org\/10.1002\/art.34651","journal-title":"Arthritis Rheum"},{"key":"5017_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/J.AMJMED.2012.09.014","volume":"126","author":"AM Abeles","year":"2013","unstructured":"Abeles AM, Abeles M (2013) The Clinical Utility of a Positive Antinuclear Antibody Test Result. Am J Med 126:342\u2013348. https:\/\/doi.org\/10.1016\/J.AMJMED.2012.09.014","journal-title":"Am J Med"},{"key":"5017_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S2665-9913(20)30084-9","volume":"2","author":"AL Yeo","year":"2020","unstructured":"Yeo AL, Le S, Ong J, Connelly K, Ojaimi S, Nim H, Morand EF, Leech M (2020) Utility of repeated antinuclear antibody tests: a retrospective database study. Lancet Rheumatol 2:412\u2013417. https:\/\/doi.org\/10.1016\/S2665-9913(20)30084-9","journal-title":"Lancet Rheumatol"},{"key":"5017_CR15","first-page":"127","volume-title":"Textbook of Pediatric Rheumatology","author":"J Akikusa","year":"2021","unstructured":"Akikusa J, Choo S (2021) Laboratory investigations. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC (eds) Textbook of Pediatric Rheumatology, 8th edn. Elsevier, Philadelphia, PA, pp 127\u2013142","edition":"8"},{"key":"5017_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/J.JMII.2011.01.019","volume":"44","author":"KY Wang","year":"2011","unstructured":"Wang KY, Yang YH, Chuang YH, Chan PJ, Yu HH, Lee JH, Wang LC, Chiang BL (2011) The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up. J Microbiol Immunol Infect 44:222\u2013228. https:\/\/doi.org\/10.1016\/J.JMII.2011.01.019","journal-title":"J Microbiol Immunol Infect"},{"key":"5017_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/PED.14592","volume":"63","author":"F Haslak","year":"2021","unstructured":"Haslak F, Yildiz M, Altun I et al (2021) Anti-nuclear antibody testing in children: How much is really necessary? Pediatr Int 63:1020\u20131025. https:\/\/doi.org\/10.1111\/PED.14592","journal-title":"Pediatr Int"},{"key":"5017_CR18","doi-asserted-by":"publisher","unstructured":"Ayg\u00fcn E, Kelesoglu FM, Dogdu G et al (2019) Antinuclear antibody testing in a Turkish pediatrics clinic: is it always necessary? Pan Afr Med J 32:181. https:\/\/doi.org\/10.11604\/PAMJ.2019.32.181.13793","DOI":"10.11604\/PAMJ.2019.32.181.13793"},{"key":"5017_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/0009922815624902","volume":"55","author":"CK Correll","year":"2016","unstructured":"Correll CK, Spector LG, Zhang L, Binstadt BA, Vehe RK (2016) Use of rheumatology laboratory studies among primary pediatricians. Clin Pediatr (Phila) 55:1279. https:\/\/doi.org\/10.1177\/0009922815624902","journal-title":"Clin Pediatr (Phila)"},{"key":"5017_CR20","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"5017_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini A, Ravelli A, Avcin T et al (2019) Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol 46:190\u2013197. https:\/\/doi.org\/10.3899\/jrheum.180168","journal-title":"J Rheumatol"},{"key":"5017_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/ART.40544\/ABSTRACT","volume":"70","author":"C Tappeiner","year":"2018","unstructured":"Tappeiner C, Klotsche J, Sengler C et al (2018) Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study. Arthritis Rheumatol 70:1685\u20131694. https:\/\/doi.org\/10.1002\/ART.40544\/ABSTRACT","journal-title":"Arthritis Rheumatol"},{"key":"5017_CR23","doi-asserted-by":"publisher","unstructured":"Storwick JA, Brett AC, Buhler K, Chin A, Schmeling H, Johnson NA, Fritzler MJ, Choi MY (2022) Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis. Autoimmun Rev 21:103086. https:\/\/doi.org\/10.1016\/J.AUTREV.2022.103086","DOI":"10.1016\/J.AUTREV.2022.103086"},{"key":"5017_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.IMLET.2011.06.001","volume":"140","author":"DA Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez DA, de Le\u00f3n AC, Varela AR, Garc\u00eda MG, de Rahola M, S, P\u00e9rez M del CR, Hern\u00e1ndez AG, Falc\u00f3n MJF, D\u00edaz BB (2011) Autoantibody detection with indirect immunofluorescence on HEp-2 cells: Starting serum dilutions for systemic rheumatic diseases. Immunol Lett 140:30\u201335. https:\/\/doi.org\/10.1016\/J.IMLET.2011.06.001","journal-title":"Immunol Lett"},{"key":"5017_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/adc.77.4.299","volume":"77","author":"PN Malleson","year":"1997","unstructured":"Malleson PN, Sailer M, Mackinnon MJ (1997) Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 77:299\u2013304. https:\/\/doi.org\/10.1136\/adc.77.4.299","journal-title":"Arch Dis Child"},{"key":"5017_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-4-13\/FIGURES\/1","volume":"4","author":"JL McGhee","year":"2004","unstructured":"McGhee JL, Kickingbird LM, Jarvis JN (2004) Clinical utility of antinuclear antibody tests in children. BMC Pediatr 4:1\u20136. https:\/\/doi.org\/10.1186\/1471-2431-4-13\/FIGURES\/1","journal-title":"BMC Pediatr"},{"key":"5017_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ACR.23292\/ABSTRACT","volume":"70","author":"N Leuchten","year":"2018","unstructured":"Leuchten N, Hoyer A, Brinks R et al (2018) Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data. Arthritis Care Res 70:428\u2013438. https:\/\/doi.org\/10.1002\/ACR.23292\/ABSTRACT","journal-title":"Arthritis Care Res"},{"key":"5017_CR28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/ANNRHEUMDIS-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151\u20131159. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"5017_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/S12016-015-8493-8","volume":"50","author":"A Floreani","year":"2016","unstructured":"Floreani A, Leung PSC, Gershwin ME (2016) Environmental Basis of Autoimmunity. Clin Rev Allergy Immunol 50:287\u2013300. https:\/\/doi.org\/10.1007\/S12016-015-8493-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"5017_CR30","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI78086","volume":"125","author":"A Marson","year":"2015","unstructured":"Marson A, Housley WJ, Hafler DA (2015) Genetic basis of autoimmunity. J Clin Invest 125:2234\u20132241. https:\/\/doi.org\/10.1172\/JCI78086","journal-title":"J Clin Invest"},{"issue":"56","key":"5017_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/S12016-017-8642-3","volume":"563","author":"M Cattalini","year":"2017","unstructured":"Cattalini M, Soliani M, Caparello MC (2017) Cimaz R (2017) Sex Differences in Pediatric Rheumatology. Clin Rev Allergy Immunol 563(56):293\u2013307. https:\/\/doi.org\/10.1007\/S12016-017-8642-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"5017_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/FIMMU.2015.00412\/BIBTEX","volume":"6","author":"EKL Chan","year":"2015","unstructured":"Chan EKL, Damoiseaux J, Carballo OG et al (2015) Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns (ICAP) 2014\u20132015. Front Immunol 6:412. https:\/\/doi.org\/10.3389\/FIMMU.2015.00412\/BIBTEX","journal-title":"Front Immunol"},{"issue":"3","key":"5017_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12291-020-00925-2","volume":"36","author":"P Gupta","year":"2021","unstructured":"Gupta P, Agrawal P, Verma RN et al (2021) Antinuclear Antibody Profiling in Patients of a Tertiary Care Centre in Central India. Indian J Clin Biochem 36(3):345\u2013352. https:\/\/doi.org\/10.1007\/s12291-020-00925-2","journal-title":"Indian J Clin Biochem"},{"key":"5017_CR34","doi-asserted-by":"publisher","unstructured":"Chauhan R, Jain D, Dorwal P, Roy G, Raina V, Nandi SP (2019) The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre. Eur Ann Allergy Clin Immunol 51:165\u2013173. https:\/\/doi.org\/10.23822\/EURANNACI.1764-1489.93","DOI":"10.23822\/EURANNACI.1764-1489.93"},{"key":"5017_CR35","doi-asserted-by":"publisher","unstructured":"Rodsaward P, Chottawornsak N, Suwanchote S et al (2021) The clinical significance of antinuclear antibodies and specific autoantibodies in juvenile and adult systemic lupus erythematosus patients. Asian Pac J Allergy Immunol 39(4):279\u2013286. https:\/\/doi.org\/10.12932\/AP-211218-0465","DOI":"10.12932\/AP-211218-0465"},{"key":"5017_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ACR.20648","volume":"64","author":"MB Urowitz","year":"2012","unstructured":"Urowitz MB, Gladman DD, Iba\u00f1ez D et al (2012) Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res 64:132\u2013137. https:\/\/doi.org\/10.1002\/ACR.20648","journal-title":"Arthritis Care Res"},{"key":"5017_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","volume":"73","author":"N Agmon-Levin","year":"2014","unstructured":"Agmon-Levin N, Damoiseaux J, Kallenberg C et al (2014) International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17\u201323. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203863","journal-title":"Ann Rheum Dis"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05017-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:10:33Z","timestamp":1689685833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05017-w"}},"subtitle":["Usefulness of ANA in pediatric autoimmune diseases"],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["5017"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05017-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Erciyes University (2018\/147).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from parents or legal guardians for each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors have no relevant financial or nonfinancial interest to disclosure.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}